Skip to content

A multicenter, randomized controlled clinical trial on Ganju Decoction for the prevention and treatment of influenza-induced respiratory tract inflammation

A multicenter, randomized controlled clinical trial on Ganju Decoction for the prevention and treatment of influenza-induced respiratory tract inflammation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000156
Enrollment
Unknown
Registered
2026-01-24
Start date
2025-06-02
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory tract inflammation

Interventions

Ganju Tang group:Ganju Tang treatment
Oseltamivir group:Oseltamivir treatment
Ganju Tang and Oseltamivir group:Ganju Tang and Oseltamivir treatment

Sponsors

Jiangyin City Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for influenza virus infection, without age, gender, or racial restrictions; 2. According to the influenza diagnosis and treatment plan (2025 version), the patients are classified as light and medium. 3. The time from onset to admission is less than 72 hours; 4. No antiviral or traditional Chinese medicine treatment was given outside the hospital; 5. Patient informed consent;

Exclusion criteria

Exclusion criteria: 1. Patients with concomitant pulmonary tuberculosis or bacterial pneumonia; 2. Patients with concomitant congenital heart disease; 3. Patients with combined autoimmune diseases; 4. Patients assessed by researchers or doctors as having severe pneumonia; 5. Those who are allergic to drugs;

Design outcomes

Primary

MeasureTime frame
Influenza virus respiratory inflammation symptom score;

Secondary

MeasureTime frame
Traditional Chinese Medicine Syndrome Points for Influenza Virus Respiratory Inflammation;Relief time for respiratory inflammation symptoms caused by influenza virus;Normalization time of body temperature;Effective time of fever reduction;Disappearance of individual symptoms;Changes in blood inflammatory index values;Changes in cytokine values;

Countries

China

Contacts

Public ContactHua Hai Bing

Jiangyin City Hospital of Traditional Chinese Medicine

jyzy3288@163.com17768318099

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026